{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:43:34Z","timestamp":1790981014776,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1012412","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000}}],"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["R21AI175463, P20GM146584 and P20GM113226"],"award-info":[{"award-number":["R21AI175463, P20GM146584 and P20GM113226"]}]},{"name":"NIH","award":["R01CA231509"],"award-info":[{"award-number":["R01CA231509"]}]},{"name":"NIH","award":["75N93022C00036"],"award-info":[{"award-number":["75N93022C00036"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Infections with the pathogenic free-living amoebae <jats:italic>Naegleria fowleri<\/jats:italic> can lead to life-threatening illnesses including catastrophic primary amoebic meningoencephalitis (PAM). Efficacious treatment options for these infections are lacking and the mortality rate remains &gt;95% in the US. Glycolysis is very important for the infectious trophozoite lifecycle stage and inhibitors of glucose metabolism have been found to be toxic to the pathogen. Recently, human enolase 2 (ENO2) phosphonate inhibitors have been developed as lead agents to treat glioblastoma multiforme (GBM). These compounds, which cure GBM in a rodent model, are well-tolerated in mammals because enolase 1 (ENO1) is the predominant isoform used systemically. Here, we describe findings that demonstrate these agents are potent inhibitors of <jats:italic>N<\/jats:italic>. <jats:italic>fowleri<\/jats:italic> ENO (<jats:italic>Nf<\/jats:italic>ENO) and are lethal to amoebae. In particular, (1-hydroxy-2-oxopiperidin-3-yl) phosphonic acid (HEX) was a potent enzyme inhibitor (IC<jats:sub>50<\/jats:sub> = 0.14 \u00b1 0.04 \u03bcM) that was toxic to trophozoites (EC<jats:sub>50<\/jats:sub> = 0.21 \u00b1 0.02 \u03bcM) while the reported CC<jats:sub>50<\/jats:sub> was &gt;300 \u03bcM. Molecular docking simulation revealed that HEX binds strongly to the active site of <jats:italic>Nf<\/jats:italic>ENO with a binding affinity of \u20138.6 kcal\/mol. Metabolomic studies of parasites treated with HEX revealed a 4.5 to 78-fold accumulation of glycolytic intermediates upstream of <jats:italic>Nf<\/jats:italic>ENO. Last, nasal instillation of HEX increased longevity of amoebae-infected rodents. Two days after infection, animals were treated for 10 days with 3 mg\/kg HEX, followed by one week of observation. At the end of the one-week observation, eight of 12 HEX-treated animals remained alive (resulting in an indeterminable median survival time) while one of 12 vehicle-treated rodents remained, yielding a median survival time of 10.9 days. However, intranasal HEX delivery was not curative as brains of six of the eight survivors were positive for amoebae. These findings suggest that HEX requires further evaluation to develop as a lead for treatment of PAM.<\/jats:p>","DOI":"10.1371\/journal.ppat.1012412","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T18:34:11Z","timestamp":1722537251000},"page":"e1012412","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Enolase inhibitors as therapeutic leads for Naegleria fowleri infection"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4872-082X","authenticated-orcid":true,"given":"Jillian E.","family":"Milanes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria C.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Dat","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Kwain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerrick C.","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian N.","family":"Dominy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Millward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Bolejack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Shek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Tillery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Q.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Staker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Ashley","family":"Moseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xipeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audriy","family":"Jebet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2515-5714","authenticated-orcid":true,"given":"James C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"issue":"7","key":"ppat.1012412.ref001","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1017\/S0950268809991014","article-title":"The epidemiology of primary amoebic meningoencephalitis in the USA, 1962\u20132008","volume":"138","author":"JS Yoder","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"5","key":"ppat.1012412.ref002","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02410-18","article-title":"Enzymatic and structural characterization of the Naegleria fowleri glucokinase","volume":"63","author":"JE Milanes","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ppat.1012412.ref003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12915-021-01078-1","article-title":"Genomics and transcriptomics yields a system-level view of the biology of the pathogen Naegleria fowleri","volume":"19","author":"EK Herman","year":"2021","journal-title":"BMC Biol"},{"issue":"3","key":"ppat.1012412.ref004","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.celrep.2018.09.055","article-title":"Lipids are the preferred substrate of the protist Naegleria gruberi, relative of a human brain pathogen.","volume":"25","author":"ML Bexkens","year":"2018","journal-title":"Cell Rep."},{"issue":"12","key":"ppat.1012412.ref005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s42255-020-00313-3","article-title":"An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.","volume":"2","author":"YH Lin","year":"2020","journal-title":"Nat Metab"},{"issue":"12","key":"ppat.1012412.ref006","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/nchembio.2195","article-title":"SF2312 is a natural phosphonate inhibitor of enolase","volume":"12","author":"PG Leonard","year":"2016","journal-title":"Nat Chem Biol"},{"issue":"5","key":"ppat.1012412.ref007","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/187152609789105687","article-title":"The Seattle Structural Genomics Center for Infectious Disease (SSGCID).","volume":"9","author":"PJ Myler","year":"2009","journal-title":"Infect Disord Drug Targets."},{"issue":"Pt 9","key":"ppat.1012412.ref008","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1107\/S1744309111029204","article-title":"Structural genomics of infectious disease drug targets: the SSGCID","volume":"67","author":"R Stacy","year":"2011","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"issue":"Pt 9","key":"ppat.1012412.ref009","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1107\/S1744309111018367","article-title":"High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease","volume":"67","author":"CM Bryan","year":"2011","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"issue":"Pt 9","key":"ppat.1012412.ref010","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1107\/S1744309111017374","article-title":"Immobilized metal-affinity chromatography protein-recovery screening is predictive of crystallographic structure success","volume":"67","author":"R Choi","year":"2011","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"issue":"Pt 5","key":"ppat.1012412.ref011","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1107\/S2053230X15004677","article-title":"Structure of an ADP-ribosylation factor, ARF1, from Entamoeba histolytica bound to Mg(2+)-GDP.","volume":"71","author":"DA Serbzhinskiy","year":"2015","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"issue":"1","key":"ppat.1012412.ref012","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"FW Studier","year":"2005","journal-title":"Protein Expr Purif"},{"issue":"Pt 2","key":"ppat.1012412.ref013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch W. Xds","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"1","key":"ppat.1012412.ref014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jmb.2011.12.024","article-title":"Dissection of the network of interactions that links RNA processing with glycolysis in the Bacillus subtilis degradosome","volume":"416","author":"JA Newman","year":"2012","journal-title":"J Mol Biol"},{"issue":"Pt 2","key":"ppat.1012412.ref015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"PD Adams","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 4","key":"ppat.1012412.ref016","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"P Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 1","key":"ppat.1012412.ref017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"VB Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"1","key":"ppat.1012412.ref018","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"HM Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"ppat.1012412.ref019","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1074\/jbc.273.23.14503","article-title":"alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci.","volume":"273","author":"V Pancholi","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"ppat.1012412.ref020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density","volume":"37","author":"C Lee","year":"1988","journal-title":"Phys Rev B Condens Matter"},{"issue":"13","key":"ppat.1012412.ref021","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24132510","article-title":"The 3S enantiomer drives enolase inhibitory activity in SF2312 and its analogues.","volume":"24","author":"F Pisaneschi","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"ppat.1012412.ref022","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"O Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"14","key":"ppat.1012412.ref023","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1039\/C9AN00560A","article-title":"Integrating comprehensive two-dimensional gas chromatography mass spectrometry and parallel two-dimensional liquid chromatography mass spectrometry for untargeted metabolomics.","volume":"144","author":"MAI Prodhan","year":"2019","journal-title":"Analyst"},{"issue":"4","key":"ppat.1012412.ref024","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1021\/ac403803a","article-title":"Data dependent peak model based spectrum deconvolution for analysis of high resolution LC-MS data","volume":"86","author":"X Wei","year":"2014","journal-title":"Anal Chem"},{"issue":"20","key":"ppat.1012412.ref025","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1021\/ac2017025","article-title":"MetSign: a computational platform for high-resolution mass spectrometry-based metabolomics","volume":"83","author":"X Wei","year":"2011","journal-title":"Anal Chem"},{"issue":"2","key":"ppat.1012412.ref026","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/14756360802187679","article-title":"Inhibition of human muscle-specific enolase by methylglyoxal and irreversible formation of advanced glycation end products","volume":"24","author":"J Pietkiewicz","year":"2009","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"2","key":"ppat.1012412.ref027","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1574-6968.2006.00274.x","article-title":"Cloning, expression and characterization of an extracellular enolase from Leuconostoc mesenteroides","volume":"259","author":"JH Lee","year":"2006","journal-title":"FEMS Microbiol Lett"},{"issue":"20","key":"ppat.1012412.ref028","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1021\/acs.jmedchem.2c01039","article-title":"Prodrugs of a 1-hydroxy-2-oxopiperidin-3-yl phosphonate enolase inhibitor for the treatment of ENO1-deleted cancers","volume":"65","author":"VC Yan","year":"2022","journal-title":"J Med Chem"},{"issue":"4793","key":"ppat.1012412.ref029","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1126\/science.2434996","article-title":"Why nature chose phosphates","volume":"235","author":"FH Westheimer","year":"1987","journal-title":"Science"},{"issue":"3","key":"ppat.1012412.ref030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031129","article-title":"Molecular Mechanisms of phosphate sensing, transport and signalling in Streptomyces and related Actinobacteria.","volume":"22","author":"JF Martin","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"1","key":"ppat.1012412.ref031","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/lol2.10100","article-title":"Phosphonate utilization by eukaryotic phytoplankton","volume":"4","author":"LP Whitney","year":"2018","journal-title":"Limnol Oceanogr Lett"},{"issue":"5","key":"ppat.1012412.ref032","doi-asserted-by":"crossref","first-page":"e0197638","DOI":"10.1371\/journal.pone.0197638","article-title":"Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors.","volume":"13","author":"S Sanders","year":"2018","journal-title":"PLoS One"},{"key":"ppat.1012412.ref033","doi-asserted-by":"crossref","first-page":"101017","DOI":"10.1016\/j.plipres.2019.101017","article-title":"The highly unnatural fatty acid profile of cells in culture","volume":"77","author":"PL Else","year":"2020","journal-title":"Prog Lipid Res"},{"issue":"9","key":"ppat.1012412.ref034","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijpara.2011.04.004","article-title":"Naegleria gruberi metabolism","volume":"41","author":"FR Opperdoes","year":"2011","journal-title":"Int J Parasitol"},{"issue":"6","key":"ppat.1012412.ref035","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02272-19","article-title":"Mycobacterial OtsA structures unveil substrate preference mechanism and allosteric regulation by 2-oxoglutarate and 2-phosphoglycerate.","volume":"10","author":"V Mendes","year":"2019","journal-title":"mBio"},{"issue":"1","key":"ppat.1012412.ref036","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-Based Guideline: Treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society.","volume":"16","author":"T Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"ppat.1012412.ref037","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2016.07.001","article-title":"A review of intranasal formulations for the treatment of seizure emergencies","volume":"237","author":"M Kapoor","year":"2016","journal-title":"J Control Release"},{"key":"ppat.1012412.ref038","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","article-title":"Evaluation of intranasal delivery route of drug administration for brain targeting","volume":"143","author":"F Erdo","year":"2018","journal-title":"Brain Res Bull"},{"key":"ppat.1012412.ref039","doi-asserted-by":"crossref","first-page":"974666","DOI":"10.3389\/fphar.2022.974666","article-title":"Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders.","volume":"13","author":"P Shah","year":"2022","journal-title":"Front Pharmacol"},{"issue":"28","key":"ppat.1012412.ref040","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1021\/acs.analchem.2c00553","article-title":"Quantification of phosphonate drugs by (1)H-(31)P HSQC shows that rats are better models of primate drug exposure than mice.","volume":"94","author":"Y Barekatain","year":"2022","journal-title":"Anal Chem"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1012412","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T17:35:22Z","timestamp":1723570522000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012412"}},"subtitle":[],"editor":[{"given":"Tomoyoshi","family":"Nozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012412","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1012412","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}